The potential interaction between TRPV1 and GLP-1-derived peptides has been elucidated through structural models
Advantage : Tirzepatide Weight Loss Efficacy# Orforglipron : ATTAIN-1 demonstrated 12.4% mean weight loss at 36 mg over 72 weeks
The SUSTAIN and SELECT trials, which enrolled tens of thousands of participants, tracked cardiovascular events and reported chest pain incidence at rates comparable to placebo groups
In preclinical research contexts, this extensive multi-receptor profile supports controlled evaluation of complex metabolic signaling and co-activation kinetics in high-sensitivity laboratory models
On one hand, IBD can lead to dysregulation of adipokines, shifting the balance towards a pro-inflammatory state, on the other hand obesity and higher BMI are associated with higher risk of developing IBD and worse clinical outcomes, particularly for UC
The medication is clearly doing something, just not producing weight loss anymore